Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Access the exclusive and authoritative pharma industry reports that only Pharma Intelligence can deliver. Encompassing a vast array of topics and disease areas, these exhaustive resources bring you the best in pharma sector reporting.
87 Total results for product and free and sample content found
Scrip
07 Feb 2020
Go inside the 2020 J.P. Morgan Healthcare Conference with exclusive reporting from Scrip. Explore the most important news from each day, and access exclusive, real-time interviews with pharma and biotech movers and shakers, and discover insights into the trends revealed at this year’s event.
Scrip
06 Feb 2020
For Scrip’s annual preview, our journalists asked over 80 industry executives and experts for their predictions of the major trends for 2020. From AI to M&A, gene therapy to the upcoming US election, here’s what to watch for as we begin this new decade.
Topic Biosimilars BioPharmaceutical
Biomedtracker, Meddevicetracker
03 Feb 2020
The 38th Annual J.P. Morgan Healthcare Conference has concluded, and Biomedtracker and Meddevicetracker were there to bring you the important outcomes from the largest and most informative annual healthcare investment symposium in the industry.
Biomedtracker, Datamonitor Healthcare
28 Jan 2020
Access vital post-ASH meeting reporting from the expert analysts at Datamonitor Healthcare and Biomedtracker.
Scrip
18 Dec 2019
Access Asia Pharma Intelligence expertise and hear from Pharma journalists across Asia to reveal deep regional expertise with this sample of Scrip's Asia 100 Report.
In Vivo
18 Dec 2019
Tap Outlook 2020’s essential coverage of medtech, R&D, clinical trials and regulation, manufacturing, and more with your extract from our most powerful report.
Pink Sheet
20 Nov 2019
Novartis finds itself facing possible criminal or civil action for admitted data manipulation on its application for Zolgensma, a gene therapy used to treat children with spinal muscular atrophy (SMA) – manipulation disclosed only after FDA approval. Pink Sheet was the first to report on the drug’s loss of EU accelerated assessment, nearly 3 weeks before the pharma giant admitted to submitting falsified data to FDA. Follow the scandal and anticipate its implications on the industry with Pink Sheet’s coverage and timeline.
Topic Cell and gene therapy FDA
Meddevicetracker
06 Nov 2019
Capture details about the worldwide market for COPD and asthma inhalation drug devices with Meddevicetracker’s “Drug Delivery: Inhalation Devices Report Extract: US, 5EU Markets, and Japan”.
Generics Bulletin
04 Nov 2019
As the push to promote the uptake of biosimilars in the US gains more momentum, new opportunities and challenges arise. Keep in tune with important developments in this impactful area using market coverage from Generics Bulletin.
Topic Biosimilars
No Records Found
Request a live demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
How can we help you?
Our team is always happy to hear from you. Please call us at:
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
